Patent · US Expired

Probe for tumour diagnostics or tumour therapy

US5747250A · kind A · utility

4Cited by

0References

13Claims

0Family size

Assignee

Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V. · US

Inventors

Peter Gruss · Göttingen, DE
Catharina Maulbecker · Zürich, CH

Key dates

Filing date	Mar 27, 1995
Grant date	May 5, 1998
Priority date	—
Expiry date	Mar 27, 2015

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A therapeutic or diagnostic agent according to the invention contains as active substance at least one nucleic acid which hybridizes with a Pax gene or at least one Pax protein or at least one antibody against a Pax protein or a derivative thereof. The agents according to the invention are used in tumour diagnosis or/and tumour therapy as well as an antisense nucleic acid for the inhibition of gene expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.